Quốc gia: Ai-len
Ngôn ngữ: Tiếng Anh
Nguồn: HPRA (Health Products Regulatory Authority)
Benazepril hydrochloride
Ecuphar NV
QC09AA07
Benazepril hydrochloride
5 mg/tablet
Tablet
POM: Prescription Only Medicine as defined in relevant national legislation
benazepril
Authorised
2006-08-24
Health Products Regulatory Authority 19 March 2019 CRN008XSS Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Benazecare Flavour 5 mg Tablets for Dogs and Cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Benazepril hydrochloride 5 mg EXCIPIENTS: For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. Beige oblong tablet with breakline on both sides. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Dogs Treatment of congestive heart failure in dogs. Cats Reduction of proteinuria associated with chronic kidney disease. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not use in cases of hypotension, hypovolaemia, hyponatraemia or acute renal failure. Do not use in cases of cardiac output failure due to aortic or pulmonary stenosis. Do not use during pregnancy or lactation (section 4.7). 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS No evidence of renal toxicity of the veterinary medicinal product has been observed (in dogs or cats) during clinical trials, however, as is routine in cases of chronic kidney disease, it is recommended to monitor plasma creatinine, urea and erythrocyte counts during therapy. The efficacy and safety of benazepril hydrochloridehas not been established in dogs and cats below 2.5 kg body weight. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Wash hands after use. In case of accidental oral ingestion, seek medical advice immediately and show the label or the package leaflet to the physician. Pregnant women should take special care to avoid accidental oral exposure because angiotensin converting enzyme (ACE) inhibitors have been found to affect the unborn child during pregnancy in humans. Health Products Regulatory Authority 19 March 2019 CRN008XSS Page 2 Đọc toàn bộ tài liệu